A research team led by Professor Lee Sang-chul of the Department of Urology at Seoul National University Bundang Hospital ...

No one wants to be diagnosed with or go through the physical and psychological toll of cancer. Which is why, sometimes, it's ...

To close out Men’s Health Month, the Cancer Connections team sat down with Dr. William Dahut, the American Cancer Society’s ...

According to the latest study from BCC Research, "Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic ...

Sam S. Chang MD, MBA, discusses intravesical mitomycin in low-grade intermediate-risk nonmuscle-invasive bladder cancer vs ...

Some cancer patients respond better to immunotherapy, radiation or chemotherapy but doctors don’t know why. A new study may ...

Dr. Jason Kim and Dr. Steven Weissbart of the Women's Pelvic Health and Continence Center at Stony Brook University Hospital ...

Pelvic floor therapy is often only associated with women who experience pelvic floor dysfunction after childbirth, but men ...

TYRA-300 is a potential first-in-class, investigational, oral, FGFR3-selective inhibitor designed to minimize the toxicities associated with inhibition of FGFR1, FGFR2 and FGFR4, while being agnostic ...

"Furthermore, they will reinforce our family history clinics to improve early detection, rapid access clinics, bladder cancer surgical care and the crucial acute oncology services. "We are also proud ...

There will be an immediate €2.3m investment in cancer care services across the South West region, with new staff and new services based mainly in CUH, along with additional resources for the Mercy in ...